2010
DOI: 10.1002/ibd.21113
|View full text |Cite
|
Sign up to set email alerts
|

Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease

Abstract: CTE affects a proportion of pediatric IBD patients. Although resolution of physical impairment is the norm, significant morbidity exists. Our study suggests a secular trend toward CTE in CD. Primary prevention with the identification and amelioration of identifiable risk factors should be the clinical objective in future studies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
18
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(20 citation statements)
references
References 45 publications
2
18
0
Order By: Relevance
“…Mean diagnosis age of the reported 20 cases was 11.7 ± 2.7 years and median value of time to development of CSVT after diagnosis of UC was 10.5 months [ranging 0.5-66.0 months] (Table I). The earliest time to development of thrombosis during disease progression was two weeks as reported by Barclay et al (7). The longest time to development of CSVT after UC was 66 months (5).…”
Section: Demographic Findingssupporting
confidence: 51%
“…Mean diagnosis age of the reported 20 cases was 11.7 ± 2.7 years and median value of time to development of CSVT after diagnosis of UC was 10.5 months [ranging 0.5-66.0 months] (Table I). The earliest time to development of thrombosis during disease progression was two weeks as reported by Barclay et al (7). The longest time to development of CSVT after UC was 66 months (5).…”
Section: Demographic Findingssupporting
confidence: 51%
“…75 Recently, it has been suggested starting LMWH in children with IBD ''and additional risk,'' as inpatient/immobilized, thrombophilia, thrombocytosis >750/mm dypiridamol) was suggested for selected ''additional risk'' patients. 15 Some general recommendations on the management of TE in children with IBD are given in Table 6. Based on the existing body of research it is difficult to provide more specific advice for pharmacoprophylaxis in children.…”
Section: Discussionmentioning
confidence: 99%
“…This is particularly important as patients with IBD and undernutrition are more likely to present higher levels of adiposity, for the same unit of BMI as healthy controls, are more prone to cardiovascular diseases [26,27] and undernutrition can affect adversely their quality of life and clinical outcomes [28]. In this study, percentage weight loss was determined using the current and last recorded weight.…”
Section: Discussionmentioning
confidence: 99%